2017 International Congress

Tuesday, June 6, 2017

1:45pm-3:15pm

Cortico-thalamic Biomarkers for a Responsive Deep Brain Stimulation: an enhanced Treatment of Essential Tremor.

E. Opri, J. Shute, R. Molina, K. Foote, M. Okun, A. Gunduz (Gainesville, FL, USA)

Tremor  ·  Exhibit Hall C

1:45pm-3:15pm

CR6-interacting factor1 Deficiency in Dopamine Neurons Triggers Early-onset Parkinsonism in Mice

I. Ryu, J. Han, Y. Jang, S.J. Kim, j. Kim, M.J. Lee, X. Ju, M.J. Ryu, S.-Y. Choi, W. Chung, E. Oh, G.R. Kweon (Daejeon, Republic of Korea)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C

1:45pm-3:15pm

D2 receptor mediated DARPP32/PP1α signaling is responsible for cadmium induced Parkinson’s like behavioral alterations in rats

R. Gupta, R. Shukla, V. Khanna (Luckno, India)

Drug-Induced Movement Disorders  ·  Exhibit Hall C

1:45pm-3:15pm

Deep Brain Stimulation (DBS) battery longevity of Medtronic Activa SC is briefer than preceding Soletra models, a within subject analysis

E. Hargreaves, R. Patel, R. DiPaola, S. Wong, D. Caputo, S. Danish (New Brunswick, NJ, USA)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C

1:45pm-3:15pm

Deferiprone combined with phlebotomy for aceruloplasminemia

L.H.P. Vroegindeweij, J.G. Langendonk, J.H.P. Wilson, A.J.W. Boon (Rotterdam, Netherlands)

Rare Genetic and Metabolic Diseases  ·  Exhibit Hall C

1:45pm-3:15pm

Demographic and Clinical Characteristics and Tetrabenazine (TBZ) Persistence in Patients With Huntington Disease (HD)-Associated Chorea

V. Sung, R. Iyer, S. Gandhi, V. Abler, B. Davis, D. Irwin, K. Anderson (Birmingham, AL, USA)

Huntington's Disease  ·  Exhibit Hall C

1:45pm-3:15pm

Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

Huntington's Disease  ·  Exhibit Hall C

1:45pm-3:15pm

Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease

A. Verma, V. Kumar, U. Singh (Allahabad, India)

Therapy in Movement Disorders  ·  Exhibit Hall C

1:45pm-3:15pm

Design and personalisation of new upper-limb dynamic orthoses for dystonia and dyskinesia

L. Garavaglia, M. Ferari, A. Lo Mauro, E. Pagliano, G. Baranello, B. Bassi, A. Aliverti, S. Pittaccio (Lecco, Italy)

Technology  ·  Exhibit Hall C

1:45pm-3:15pm

Design of a randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD)

H. Drechsel, U. Malzahn, C. Roeser, P. Heuschmann, J. Volkmann (Würzburg, Germany)

Therapy in Movement Disorders  ·  Exhibit Hall C